RE:Newstrike way overvaluedThey can bring HIP along for the ride and it was stated as so in the lastest news release.
CanniMed said it has now postponed its shareholder meeting by two days so it could discuss "a possible transaction" with Aurora. It gave no assurance that a deal would result. The two sides declined to discuss the details, having signed a standstill agreement while the talks proceeded
"Let's see what comes of this. You go into something like this with an open mind and see if you can make good things happen," Cam Battley, Aurora's chief corporate officer, said in an interview.
Sources familiar with the discussions said Aurora is now open to the idea of allowing Newstrike into the deal.
The proposed share exchange would likely have to be sweetened as well, given the runup in CanniMed stock, which has more than doubled since Aurora first disclosed it was interested in a deal in November.